Measuring Long-term Disease Control in Atopic Dermatitis: a Validation Study of Well Controlled Weeks.


Langan, SM; Stuart, B; Bradshaw, L; Schmitt, J; Williams, HC; Thomas, KS; (2017) Measuring Long-term Disease Control in Atopic Dermatitis: a Validation Study of Well Controlled Weeks. The Journal of allergy and clinical immunology. ISSN 0091-6749 DOI: https://doi.org/10.1016/j.jaci.2017.02.043

[img]
Preview
Text - Accepted Version
License:

Download (370kB) | Preview
[img]
Preview
Text - Accepted Version
License:

Download (200kB) | Preview
[img]
Preview
Text - Accepted Version
License:

Download (107kB) | Preview

Abstract

Because atopic dermatitis (AD) is a relapsing, remitting disease, assessing long-term control is important. Well controlled weeks (WCWs) have been used to assess asthma long-term control, but never validated for AD. To assess feasibility, validity and interpretability of WCWs in AD patients. Three studies of patients with moderate-to-severe AD including 4-6 months of daily/weekly symptom and treatment use data were evaluated (Study A: n=336; Study B: n=60; Study C: n=224). WCWs were defined by worsening symptoms and increased medication use. Feasibility, construct validity and interpretability of WCWs were determined by assessing missing data, association with validated AD outcomes, and floor/ceiling effects. Analysis used linear and logistic regression. WCWs were feasible to collect - 95.2% (study A) and 94.7% (study B) contributed data for at least half of the weekly data-points, and 93.2% and 88.7% contributed to all data-points up to 4 months. WCWs were significantly associated with validated AD severity instruments including patient-reported (POEM) and objective signs (EASI, TIS and SASSAD). The odds of experiencing a WCW if AD severity was clear/mild was 5.8 (95% confidence interval (CI) 3.5 to 9.7), 1.9 (95%CI 0.8 to 4.4) and 8.1 (95%CI 4.5 to 14.6) in Studies A, B and C, respectively. WCWs were associated with ceiling effects- 31.6% (study A) and 37.5% (study B) of participants had no WCWs for >90% of the time. WCWs are valid and feasible for measuring long-term control in AD trials. However, ceiling effects and burden of data collection may limit use.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
Research Centre: EHR Research Group
PubMed ID: 28456619
URI: http://researchonline.lshtm.ac.uk/id/eprint/3851062

Statistics


Download activity - last 12 months
Downloads since deposit
18Downloads
34Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item